Insider Selling: Heartflow (NASDAQ:HTFL) CEO Sells $1,470,420.00 in Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 32,676 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $45.00, for a total transaction of $1,470,420.00. Following the completion of the sale, the chief executive officer directly owned 388,044 shares of the company’s stock, valued at approximately $17,461,980. This trade represents a 7.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Friday, August 14th, John C.M. Farquhar sold 15,560 shares of Heartflow stock. The stock was sold at an average price of $39.06, for a total transaction of $607,773.60.
• On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total transaction of $638,730.22.
• On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $27.75, for a total transaction of $626,095.50.
• On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The stock was sold at an average price of $35.00, for a total value of $1,361,500.00.
• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total value of $643,017.00.

Heartflow Stock Up 6.3%

Heartflow stock opened at $49.75 on Friday. The business has a 50 day moving average price of $30.66 and a two-hundred day moving average price of $28.32. The stock has a market cap of $4.33 billion and a price-to-earnings ratio of -27.19. Heartflow, Inc. has a 12 month low of $20.13 and a 12 month high of $50.48.

Heartflow (NASDAQ:HTFL) last issued its earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.15. The firm had revenue of $64.08 million during the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The firm’s quarterly revenue was up 47.7% compared to the same quarter last year. On average, analysts expect that Heartflow, Inc. will post -0.82 earnings per share for the current fiscal year.

Analyst Ratings Changes

HTFL has been the topic of a number of analyst reports. Weiss Ratings raised shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 7th. Wells Fargo & Company upped their price objective on Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. Benchmark reissued a “buy” rating on shares of Heartflow in a report on Friday, August 14th. Morgan Stanley raised their target price on Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a research report on Friday, August 14th. Finally, Robert W. Baird set a $45.00 price target on Heartflow in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $43.43.

Hedge Funds Weigh In On Heartflow

Institutional investors have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd bought a new stake in Heartflow during the fourth quarter worth about $27,000. Russell Investments Group Ltd. acquired a new stake in shares of Heartflow during the fourth quarter worth approximately $45,000. Essential Partners LLC bought a new position in shares of Heartflow in the first quarter valued at approximately $57,000. Legal & General Group Plc acquired a new position in shares of Heartflow in the 3rd quarter worth approximately $59,000. Finally, Strs Ohio bought a new stake in Heartflow during the 4th quarter worth approximately $99,000.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.